British pharmaceutical firm BTG has announced the arrival of a new treatment for varicose veins. The company's product, Varithena, offers a minimally invasive treatment that is capable of dissolving the veins without the need for surgery. Varithena has received the FDA approval and should be available in the market in the second quarter of 2014. This new treatment which targets both the symptoms and appearance of varicose veins employs ...Friday, 29 November 2013
FDA Approves Novel Varicose Vein Treatment With Varithena
British pharmaceutical firm BTG has announced the arrival of a new treatment for varicose veins. The company's product, Varithena, offers a minimally invasive treatment that is capable of dissolving the veins without the need for surgery. Varithena has received the FDA approval and should be available in the market in the second quarter of 2014. This new treatment which targets both the symptoms and appearance of varicose veins employs ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment